Basit öğe kaydını göster

dc.contributor.authorGüven, Münevver
dc.contributor.authorAtakul, Tolga
dc.contributor.authorÇelik, Serkan Yaşar
dc.contributor.authorYılmaz, Mustafa
dc.contributor.authorDemirci, Buket
dc.date.accessioned2022-04-14T11:41:27Z
dc.date.available2022-04-14T11:41:27Z
dc.date.issued2022en_US
dc.identifier.citationGüven M, Atakul T, Çelik SY, Yılmaz M, Demirci B. The effects of acitretin on ovarian reserve: An experimental study in rats. Turkderm-Turk Arch Dermatol Venereol 2022;56:24-7en_US
dc.identifier.issn2717-6398
dc.identifier.issn2651-5164
dc.identifier.urihttps://hdl.handle.net/20.500.12809/9908
dc.description.abstractBackground and Design: Acitretin is widely used on many dermatological diseases. No adequate studies have evaluated its effects on ovarian reserve. Thus, this expo m mental study aimed to investigate the possible effects of acitretin on ovarian reserve by examining ovarian follicle counts and serum anti-Mullerian hormone (AMH) values. Materials and Methods: This study randomly distributed 31 female Wistar albino rats into 3 groups including one control group (group 1) and two equal experimental groups. Acitretin was given at doses of 0 mg/kg/day (group 1, n-11), 1 mg/kg/day (group 2, n-10), and 5 mg/ kg/day (group 3, n-10) for 4 weeks. All the rats in three groups were kept drug-free for 4 weeks before being sacrificed. The blood samples and both ovarian tissues were obtained from the rats. Serum values of AMH were assessed and the number of ovarian follicles was counted by histopathological examination. Results: The AMH levels were lower in both acitretin groups (groups 2 and 3) than group 1. However, no significant difference was found between the groups in terms of AMI i values (p=0.338). Primordial, secondary, tertiary, and total follicle numbers in group 3 were statistically lower than that of groups 1 and 2. The number of primary follicles in group 1 was statistically higher than that of groups 2 and 3. Additionally, the number of secondary follicles in group 2 was statistically higher than that of group 1. Conclusion: This study showed that ovarian reserve can be affected by acitretin treatment. Particularly, high doses of acitretin may reduce ovarian reserve. Further experimental and clinical studies are needed to clarify the effect of acitretin on ovarian reserve.en_US
dc.item-language.isoengen_US
dc.publisherERI ZUHREVI HASTALIKLAR DERNEGIen_US
dc.relation.isversionof10.4274/turkderm.galenos.2021.37650en_US
dc.item-rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAsitretinen_US
dc.subjectAnti-Müllerian hormonen_US
dc.subjectOver rezervien_US
dc.titleThe effects of acitretin on ovarian reserve: An experimental study in ratsen_US
dc.item-title.alternativeAsitretin’in over rezervi üzerine etkisi: Sıçanlarda deneysel bir çalışmaen_US
dc.item-typearticleen_US
dc.contributor.departmentMÜ, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümüen_US
dc.contributor.authorID0000-0001-6557-1451en_US
dc.contributor.institutionauthorÇelik, Serkan Yaşar
dc.identifier.volume56en_US
dc.identifier.issue1en_US
dc.identifier.startpage24en_US
dc.identifier.endpage27en_US
dc.relation.journalTURKDERM-TURKISH ARCHIVES OF DERMATOLOGY AND VENEROLOGYen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster